A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells

• Main Authors: Ma, B., Goh, B.C., Tan, E.H., Lam, K.C., Soo, R., Leong, S.S., Wang, L.Z., Mo, F., Chan, A.T.C., Zee, B., Mok, T.
• 其他作者: PHARMACY
• 格式: Article
• 出版: 2014
• 主題: 3-AP; Gemcitabine; Methemoglobinemia; Non-small-cell lung cancer; Triapine
• 在線閱讀: http://scholarbank.nus.edu.sg/handle/10635/105569

Investigational New Drugs